233 related articles for article (PubMed ID: 28711080)
1. Menopause and Chronic Kidney Disease.
Ahmed SB
Semin Nephrol; 2017 Jul; 37(4):404-411. PubMed ID: 28711080
[TBL] [Abstract][Full Text] [Related]
2. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.
Dumanski SM; Ramesh S; James MT; Metcalfe A; Nerenberg K; Seely EW; Robertson HL; Ahmed SB
Syst Rev; 2017 Jul; 6(1):134. PubMed ID: 28683787
[TBL] [Abstract][Full Text] [Related]
3. Permanent cessation of menses and postmenopausal hormone use in dialysis-dependent women: the HELP study.
Kramer HM; Curhan GC; Singh A;
Am J Kidney Dis; 2003 Mar; 41(3):643-50. PubMed ID: 12612988
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and clinical and surrogate cardiovascular endpoints in women with chronic kidney disease: a systematic review and meta-analysis.
Ramesh S; Mann MC; Holroyd-Leduc JM; Wilton SB; James MT; Seely EW; Ahmed SB
Menopause; 2016 Sep; 23(9):1028-37. PubMed ID: 27433866
[TBL] [Abstract][Full Text] [Related]
5. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
6. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
7. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
8. DHEA, important source of sex steroids in men and even more in women.
Labrie F
Prog Brain Res; 2010; 182():97-148. PubMed ID: 20541662
[TBL] [Abstract][Full Text] [Related]
9. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
Nocke W
Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
[TBL] [Abstract][Full Text] [Related]
10. Sex hormones in women with kidney disease.
Ahmed SB; Ramesh S
Nephrol Dial Transplant; 2016 Nov; 31(11):1787-1795. PubMed ID: 27190328
[TBL] [Abstract][Full Text] [Related]
11. Is the menopause transition managed as well as it could be in women with chronic kidney disease including those undergoing renal transplant? One of the most under-recognised and neglected patient problems in clinical nephrology.
Briggs P
Post Reprod Health; 2020 Sep; 26(3):167-169. PubMed ID: 32997589
[No Abstract] [Full Text] [Related]
12. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
Armeni E; Paschou SA; Goulis DG; Lambrinoudaki I
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101561. PubMed ID: 34274232
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
[TBL] [Abstract][Full Text] [Related]
14. Menopause in CKD.
Vellanki K; Hou S
Am J Kidney Dis; 2018 May; 71(5):710-719. PubMed ID: 29530509
[TBL] [Abstract][Full Text] [Related]
15. Sex hormones and headache.
Silberstein SD
Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
[TBL] [Abstract][Full Text] [Related]
16. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
[TBL] [Abstract][Full Text] [Related]
17. Action of estrogens in the aging brain: dementia and cognitive aging.
Henderson VW
Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
Rosano GM; Vitale C; Fini M
Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
[TBL] [Abstract][Full Text] [Related]
19. Oral estrogen therapy in postmenopausal women is associated with loss of kidney function.
Ahmed SB; Culleton BF; Tonelli M; Klarenbach SW; Macrae JM; Zhang J; Hemmelgarn BR;
Kidney Int; 2008 Aug; 74(3):370-6. PubMed ID: 18496507
[TBL] [Abstract][Full Text] [Related]
20. A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.
Stevenson JC
Maturitas; 2011 Oct; 70(2):197-205. PubMed ID: 21788109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
